A retrospective study of treatment of cerebral toxoplasmosis in AIDS patients with trimethoprim-sulphamethoxazole

Journal of Infection

Volumn 37, Issue 1, 1998, Pages 15-18

  Torre, D ^a   Speranza, F ^a   Martegani, R ^a   Zeroli, C ^a   Banfi, M ^a   Airoldi, M ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD TOXICITY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SKIN MANIFESTATION; TOXOPLASMOSIS;

EID: 0031665712     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)90217-1     Document Type: Article

References (16)

1. Luft BJ, Hafner R, Korzun AH et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993; 329: 996-1000.
2. Luft BJ, Conley FK, Remington JS. Outbreak of central nervous system toxoplasmosis in Western Europe and North America. Lancet 1983; 1: 781-784.
3. Luft BJ, Brooks RG, Conley FK et al. Toxoplasmic encephalitis in patients with AIDS. JAMA 1984; 252: 913-917.
4. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-222.
5. Leport C, Raffi F, Matheron S et al. Treatment of central nervous system toxoplasmosis with pyrimethamine-sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous treatment. Am J Med 1988; 84: 94-100.
6. Georgiev VT. Opportunistic nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis. Med Res Rev 1993; 13: 529-568.
7. Haverkos HW. Assessment of therapy of toxoplasma encephalitis. The TE study group. Am J Med 1987; 82: 907-914.
8. Dannemann B, McCutchan JA, Israelski D et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med 1992; 116: 33-43.
9. Canessa A, Del Bono V, De Leo P, Piersantelli N, Terragna A. Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients. Eur J Clin Microbiol Infect Dis 1992; 11: 125-130.
10. Weiss LM, Harris C, Berger M, Tanowitz HB, Wittner M. Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with AIDS. J Infect Dis 1988; 157: 580-583.
11. Solbreux P, Sonnet J, Zech F. A retrospective study about the use of cotrimoxazole as diagnostic support and treatment of suspected cerebral toxoplasmosis in AIDS. Acta Clin Belg 1990; 45: 85-96.
12. Young LS, Hindler J. Use of trimethoprim-sulphamethoxazole singly and in combination with other antibiotics in immunocompromised patients. Rev Infect Dis 1987; 9 (Suppl. 2): S177-S183.
13. Svedhem A, Iwarson S. Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment. J Antimicrob Chemother 1979; 5: 717-720.
14. Dudley MN, Levitz RE, Quintiliani R, Hickingbotham JM, Nightgale LH. Pharmacokinetics of trimethoprim and sulphamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges. Antimicrob Agents Chemother 1984; 26: 811-814.
15. Gordin FM, Simon GL, Wosfy CB. Adverse reactions to trimethoprim sulphamethoxazole in acquired immunodeficiency syndrome. Ann Intern Med 1984; 100: 495-499.
16. Caumes E, Roudier C, Rogeaux O, Bricaire F, Gentilini M. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulphamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia. Clin Infect Dis 1994; 18: 319-323.